Skip to main content
. 2019 Oct 18;26(3):133–139. doi: 10.5761/atcs.oa.19-00202

Table 1. Patient characteristics.

Control (N = 11) Combination therapy (N = 6) p value

Age (years) 69.7 ± 2.3 67.7 ± 1.4 0.542
Body mass index (kg/m2) 22.0 ± 0.7 21.1 ± 1.3 0.268
Male N (%) 10 (91) 4 (67) 0.515
Smoking history 0.600
 Never 4 (36) 1 (17)
 Former 7 (64) 5 (83)
 Current 0 (0) 0 (0)
Pack-years 31.5 ± 10.2 31.8 ± 8.2 0.985
ASA performance status 0.353
 ≤_2 11 (100) 5 (83)
 ≥_3 0 (0) 1 (17)
Tumor location 0.304
 Ut 0 (0) 0 (0.0)
 Mt 5 (45) 5 (83)
 Lt 6 (55) 1 (17)
Tumor stage 0.171
 0/I 8 (73) 5 (83)
 II 3 (27) 0 (0)
 III 0 (0) 1 (17)
Preoperative chemotherapy 7 (64) 2 (33) 0.335
Lung function
 Obstructive disorder (FEV1.0%<70%) 1 (9.1) 0 (0.0) 1.000
 Restrictive disorder (%VC<80%) 0 (0.0) 0 (0.0) 1.000
 Unknown 1 (9.1) 0 (0.0) N.A

Values are expressed as the mean ± standard error of the mean or the number (percent).

ASA: American Society of Anesthesiologists; FEV: forced expiratory volume; N.A: not available; Ut: upper; Mt: middle; Lt: lower